Pfizer 400 Pill - orange oval, 18mm
Generic Name: bosutinib
Pill with imprint Pfizer 400 is Orange, Oval and has been identified as Bosulif 400 mg. It is supplied by Pfizer Inc.
Bosulif is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Bosulif 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer 400
Bosulif
- Generic Name
- bosutinib
- Imprint
- Pfizer 400
- Strength
- 400 mg
- Color
- Orange
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0193
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
povidone k25,
magnesium stearate,
titanium dioxide,
polyethylene glycol 3350,
magnesium silicate,
ferric oxide red,
poloxamer 188
Note: Inactive ingredients may vary.
More about Bosulif (bosutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
